TCTR20191025002尚未招募3 期
Trimethoprim/Sulfamethoxazole for Pneumocystis jirovecii Pneumonia prophylaxis in B-cell lymphoma patients receiving chemotherapy: A multicenter randomized double-blinded placebo-controlled trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 328
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 0 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. Diffused larged B-cell lymphoma patients (DLBCL), 18 years of age or older
- •2. Intent to or receiving chemotherapy with CHOP or R-CHOP not more than 3 cycles
排除标准
- •1. Receiving Trimethoprim/Sulfamethoxazole or Dapsone for pneumocystis jirovecii pneumonia prophylaxis before recruitment
- •2. History of pneumocystis jirovecii pneumonia before recruitment
- •3. Receiving Trimethoprim/Sulfamethoxazole or Dapson within 1 month before recruitment
- •4. Severe adverse reaction or allergic to Trimethoprim/Sulfamethoxazole or sulfa drug
- •5. Creatinine clearance < 30 mg/dL
- •6. Women who were pregnant or during breast feeding
研究者
相似试验
已完成
不适用
Retrospective Observational Study of Cotrimoxazole Dosing in Intensive Care UnitAcute Kidney InjuryNCT05221216Centre Hospitalier Universitaire de Saint Etienne5
Unknown
2 期
Study of Trimethoprim/Sulfamethoxazole as PCP Prophylaxis in CTD PatientsPneumonia, PneumocystisPrevention & ControlNCT01747278Peking Union Medical College Hospital80
已完成
不适用
Cotrimoxazol to prevent malaria in HIV-infected pregnant women in Sub-Saharan AfricaISRCTN98835811AlterSanté (France)300
招募中
3 期
Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii PneumoniaPneumocystis PneumoniaPneumocystisPneumocystis Jirovecii InfectionPneumocystis InfectionsPneumocystis Carinii InfectionPneumocystosis; Pneumonia (Etiology)Pneumocystosis Associated With AIDSPneumocystis Carinii Infection, Resulting From HIV DiseaseNCT04851015Todd C. Lee MD MPH FIDSA416
已完成
2 期
A study of role of trimethoprim-sulfamethoxazole in opportunistic infection prevention in lupus patients taking low-level immunosuppressive treatmentTrimethoprim-sulfamethoxazole primary prophylaxis in lupus patients taking low-level immunosuppressive treatmentLupusTrimethoprim-sulfamethoxazolePneumocystis pneumoniaSystemic lupus erythematosusTCTR20230606002Mahidol university138